Idursulfase-IT: Clinical Trials

3 completed, 1 active not recruiting, 1 available. 4 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	4	Completed 3, Active not recruiting 1
Phase 3	3	Completed 2, Active not recruiting 1
Phase 1	1	Completed 1

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment Idursulfase-IT, Elaprase - Hunter Syndrome	Phase 2 / Phase 3	Active not recruiting	Takeda	6	2024-03-05	2025-11-06
Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094 Idursulfase-IT, Elaprase - Hunter Syndrome	Phase 2 / Phase 3	Completed	Shire	56	2015-04-14	2025-06-19
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment idursulfase-IT, No IT treatment - Hunter Syndrome	Phase 2 / Phase 3	Completed	Shire	58	2014-03-24	2021-06-11
An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment Idursulfase-IT, Elaprase - Hunter Syndrome	Phase 1 / Phase 2	Completed	Takeda	15	2010-08-01	2025-08-06
Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome Idursulfase-IT - Hunter Syndrome		Available	Takeda			2026-04-13

Canada (4) · United Kingdom (4) · United States (4) · Australia (3) · France (3) · Mexico (3) · Spain (3)

2014 (1), 2023 (1)